Correlation Between Alligator Bioscience and Arctic Blue

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alligator Bioscience and Arctic Blue at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alligator Bioscience and Arctic Blue into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alligator Bioscience AB and Arctic Blue Beverages, you can compare the effects of market volatilities on Alligator Bioscience and Arctic Blue and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alligator Bioscience with a short position of Arctic Blue. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alligator Bioscience and Arctic Blue.

Diversification Opportunities for Alligator Bioscience and Arctic Blue

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Alligator and Arctic is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Alligator Bioscience AB and Arctic Blue Beverages in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arctic Blue Beverages and Alligator Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alligator Bioscience AB are associated (or correlated) with Arctic Blue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arctic Blue Beverages has no effect on the direction of Alligator Bioscience i.e., Alligator Bioscience and Arctic Blue go up and down completely randomly.

Pair Corralation between Alligator Bioscience and Arctic Blue

Assuming the 90 days trading horizon Alligator Bioscience AB is expected to generate 9.89 times more return on investment than Arctic Blue. However, Alligator Bioscience is 9.89 times more volatile than Arctic Blue Beverages. It trades about -0.03 of its potential returns per unit of risk. Arctic Blue Beverages is currently generating about -0.31 per unit of risk. If you would invest  11.00  in Alligator Bioscience AB on September 12, 2024 and sell it today you would lose (10.80) from holding Alligator Bioscience AB or give up 98.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy98.46%
ValuesDaily Returns

Alligator Bioscience AB  vs.  Arctic Blue Beverages

 Performance 
       Timeline  
Alligator Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alligator Bioscience AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Arctic Blue Beverages 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arctic Blue Beverages has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Alligator Bioscience and Arctic Blue Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alligator Bioscience and Arctic Blue

The main advantage of trading using opposite Alligator Bioscience and Arctic Blue positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alligator Bioscience position performs unexpectedly, Arctic Blue can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arctic Blue will offset losses from the drop in Arctic Blue's long position.
The idea behind Alligator Bioscience AB and Arctic Blue Beverages pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance